Detalles de la búsqueda
1.
Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
Parasitol Res;
117(2): 391-403, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29248978
2.
An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.
Parasitol Res;
115(11): 4083-4095, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27365053
3.
Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.
Parasitology;
142(10): 1335-47, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099574
4.
Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
Exp Parasitol;
153: 180-90, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25845753
5.
Comparative evaluation of phenol and thimerosal as preservatives for a candidate vaccine against American cutaneous leishmaniasis.
Mem Inst Oswaldo Cruz;
105(1): 86-91, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20209335
6.
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
Basic Clin Pharmacol Toxicol;
123(3): 236-246, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481714
7.
A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
Immunobiology;
222(2): 251-260, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693018
8.
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.
Rev Soc Bras Med Trop;
49(4): 398-407, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27598624
9.
An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Vet Parasitol;
217: 81-8, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26827866
10.
A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.
Acta Trop;
154: 73-81, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26593442
11.
Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system.
Parasitol Int;
65(6 Pt A): 728-736, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27425599
12.
Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
Acta Trop;
158: 220-230, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26976272
13.
Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
Vet Parasitol;
215: 63-71, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26790739
14.
New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.
Expert Opin Ther Pat;
25(3): 247-60, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530084
15.
Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapy.
Rev Soc Bras Med Trop;
48(4): 370-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26312925
16.
New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment.
Rev Soc Bras Med Trop;
48(3): 235-42, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26107999
17.
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis.
PLoS One;
10(9): e0137683, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26367128
18.
Detection and characterization of leishmania antigens from an American cutaneous leishmaniasis vaccine for diagnosis of visceral leishmaniasis.
Diagn Microbiol Infect Dis;
45(1): 35-43, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12573549
19.
Synergistic action of praziquantel and host specific immune response against Schistosoma mansoni at different phases of infection.
Rev Inst Med Trop Sao Paulo;
46(4): 231-3, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15361976
20.
Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
PLoS One;
9(10): e110014, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25333662